What does the Nu.Q^® Vet Cancer Test measure?

High cellular turnover – due to diseases like cancer – can lead to an increased concentration of nucleosomes in the bloodstream. They can be captured using antibodies tailored specifically to detect nucleosomes.

The Nu.Q^® Vet Cancer Test quantifies these circulating nucleosome levels in the blood. The test needs just 0.5ml of plasma, obtainable from a 2-5ml blood draw after centrifugation.

By measuring and analyzing nucleosomes, our Nu.Q^® Vet Cancer Test can help identify patients who may have a cancer. This must then be confirmed by follow-up procedures – for example, a biopsy or scan. 

What types of cancer has the Nu.Q^® Vet Cancer Test been able to detect?

The Nu.Q^® Vet Cancer Test can detect cancers such as lymphoma and hemangiosarcoma, even at early stages. Preliminary data suggests that this screening test can also detect some instances of Mast Cell tumours, malignant melanomas and Histiocytic Sarcoma. The current Nu.Q^® Vet Cancer Test more reliably detects systemic cancers rather than soft tissue or localized cancers.

How to take a sample and interpret the results

Visit our Nu.Q^® Vet Cancer Test product information page for a step-by-step guide on how to take a sample from your patient and interpret the results.